BACKGROUND Sedation with propofol injections is associated with a risk of addiction,but remimazolam benzenesulfonate is a comparable anesthetic with a short elimination half-life and independence from cell P450 enzyme...BACKGROUND Sedation with propofol injections is associated with a risk of addiction,but remimazolam benzenesulfonate is a comparable anesthetic with a short elimination half-life and independence from cell P450 enzyme metabolism.Compared to remimazolam,remimazolam benzenesulfonate has a faster effect,is more quickly metabolized,produces inactive metabolites and has weak drug interactions.Thus,remimazolam benzenesulfonate has good effectiveness and safety for diagnostic and operational sedation.AIM To investigate the clinical value of remimazolam benzenesulfonate in cardiac surgery patients under general anesthesia.METHODS A total of 80 patients who underwent surgery in the Department of Cardiothoracic Surgery from August 2020 to April 2021 were included in the study.Using a random number table,patients were divided into two anesthesia induction groups of 40 patients each:remimazolam(0.3 mg/kg remimazolam benzenesulfonate)and propofol(1.5 mg/kg propofol).Hemodynamic parameters,inflammatory stress response indices,respiratory function indices,perioperative indices and adverse reactions in the two groups were monitored over time for comparison.RESULTS At pre-anesthesia induction,the remimazolam and propofol groups did not differ regarding heart rate,mean arterial pressure,cardiac index or volume per wave index.After endotracheal intubation and when the sternum was cut off,mean arterial pressure and volume per wave index were significantly higher in the remimazolam group than in the propofol group(P<0.05).After endotracheal intubation,the oxygenation index and the respiratory index did not differ between the groups.After endotracheal intubation and when the sternum was cut off,the oxygenation index values were significantly higher in the remimazolam group than in the propofol group(P<0.05).Serum interleukin-6 and tumor necrosis factor-αlevels 12 h after surgery were significantly higher than before surgery in both groups(P<0.05).The observation indices were re-examined 2 h after surgery,and the epinephrine,cortisol and blood glucose levels were significantly higher in the remimazolam group than in the propofol group(P<0.05).The recovery and extubation times were significantly lower in the remimazolam group than in the propofol group(P<0.05);there were significantly fewer adverse reactions in the remimazolam group(10.00%)than in the propofol group(30.00%;P<0.05).CONCLUSION Compared with propofol,remimazolam benzenesulfonate benefited cardiac surgery patients under general anesthesia by reducing hemodynamic fluctuations.Remimazolam benzenesulfonate influenced the surgical stress response and respiratory function,thereby reducing anesthesia-related adverse reactions.展开更多
目的探讨心肺复苏后多器官功能障碍综合征(MODS)发病危险因素和预后。方法回顾分析53例心跳骤停(CA)心肺复苏自主循环恢复(ROSC)患者资料。结果48例发生MODS(90.6%),死亡35例(66.0%)。复苏前时间≥6 m in组10例均发生MODS和死亡。即刻...目的探讨心肺复苏后多器官功能障碍综合征(MODS)发病危险因素和预后。方法回顾分析53例心跳骤停(CA)心肺复苏自主循环恢复(ROSC)患者资料。结果48例发生MODS(90.6%),死亡35例(66.0%)。复苏前时间≥6 m in组10例均发生MODS和死亡。即刻复苏组43例,MODS38例,发病率和死亡率在CA-ROSC间期<10 m in组分别低于≥10 m in组(77.3%vs 100.0%、P<0.01;27.3%vs93.5%、P<0.005),ROSC后SIRS 48例均伴发MODS。发病率与年龄、既往慢性病、电除颤项目无关(P>0.05),肾上腺素用量≤5 mg组低于>5 mg组(P<0.005)。结论复苏后MODS发病危险因素包括ROSC间期≥6 m in、CA-ROSC间期≥10 m in、复苏后SIRS,应及时评估和防治患者器官功能。展开更多
基金The First Affiliated Hospital of Nanchang University Ethics Committee.
文摘BACKGROUND Sedation with propofol injections is associated with a risk of addiction,but remimazolam benzenesulfonate is a comparable anesthetic with a short elimination half-life and independence from cell P450 enzyme metabolism.Compared to remimazolam,remimazolam benzenesulfonate has a faster effect,is more quickly metabolized,produces inactive metabolites and has weak drug interactions.Thus,remimazolam benzenesulfonate has good effectiveness and safety for diagnostic and operational sedation.AIM To investigate the clinical value of remimazolam benzenesulfonate in cardiac surgery patients under general anesthesia.METHODS A total of 80 patients who underwent surgery in the Department of Cardiothoracic Surgery from August 2020 to April 2021 were included in the study.Using a random number table,patients were divided into two anesthesia induction groups of 40 patients each:remimazolam(0.3 mg/kg remimazolam benzenesulfonate)and propofol(1.5 mg/kg propofol).Hemodynamic parameters,inflammatory stress response indices,respiratory function indices,perioperative indices and adverse reactions in the two groups were monitored over time for comparison.RESULTS At pre-anesthesia induction,the remimazolam and propofol groups did not differ regarding heart rate,mean arterial pressure,cardiac index or volume per wave index.After endotracheal intubation and when the sternum was cut off,mean arterial pressure and volume per wave index were significantly higher in the remimazolam group than in the propofol group(P<0.05).After endotracheal intubation,the oxygenation index and the respiratory index did not differ between the groups.After endotracheal intubation and when the sternum was cut off,the oxygenation index values were significantly higher in the remimazolam group than in the propofol group(P<0.05).Serum interleukin-6 and tumor necrosis factor-αlevels 12 h after surgery were significantly higher than before surgery in both groups(P<0.05).The observation indices were re-examined 2 h after surgery,and the epinephrine,cortisol and blood glucose levels were significantly higher in the remimazolam group than in the propofol group(P<0.05).The recovery and extubation times were significantly lower in the remimazolam group than in the propofol group(P<0.05);there were significantly fewer adverse reactions in the remimazolam group(10.00%)than in the propofol group(30.00%;P<0.05).CONCLUSION Compared with propofol,remimazolam benzenesulfonate benefited cardiac surgery patients under general anesthesia by reducing hemodynamic fluctuations.Remimazolam benzenesulfonate influenced the surgical stress response and respiratory function,thereby reducing anesthesia-related adverse reactions.
文摘目的探讨心肺复苏后多器官功能障碍综合征(MODS)发病危险因素和预后。方法回顾分析53例心跳骤停(CA)心肺复苏自主循环恢复(ROSC)患者资料。结果48例发生MODS(90.6%),死亡35例(66.0%)。复苏前时间≥6 m in组10例均发生MODS和死亡。即刻复苏组43例,MODS38例,发病率和死亡率在CA-ROSC间期<10 m in组分别低于≥10 m in组(77.3%vs 100.0%、P<0.01;27.3%vs93.5%、P<0.005),ROSC后SIRS 48例均伴发MODS。发病率与年龄、既往慢性病、电除颤项目无关(P>0.05),肾上腺素用量≤5 mg组低于>5 mg组(P<0.005)。结论复苏后MODS发病危险因素包括ROSC间期≥6 m in、CA-ROSC间期≥10 m in、复苏后SIRS,应及时评估和防治患者器官功能。
